Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis

Drug Development and Industrial Pharmacy

Volumn 43, Issue 6, 2017, Pages 1003-1010

  Bhalekar, Mangesh R ^a   Madgulkar, Ashwini R ^a   Desale, Puja S ^a   Marium, Gyce ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

Author keywords

CIA; ELISA; optimization; piperine; Rheumatoid arthritis; SLN (solid lipid nanoparticles); TNF

Indexed keywords

CHLOROQUINE; PIPERINE; SOLID LIPID NANOPARTICLE; TUMOR NECROSIS FACTOR; 1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; EXCIPIENT; FREUND ADJUVANT; LIPID; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERIDINE DERIVATIVE; SURFACTANT;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FREUND ADJUVANT-INDUCED ARTHRITIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NANOEMULSION; NONHUMAN; PARTICLE SIZE; RAT; RHEUMATOID ARTHRITIS; SKIN; TREATMENT OUTCOME; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION; ZETA POTENTIAL; ANIMAL; ARTHRITIS, EXPERIMENTAL; CHEMICALLY INDUCED; CHEMISTRY; IN VITRO STUDY; WISTAR RAT;

ALKALOIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BENZODIOXOLES; DRUG COMPOUNDING; EXCIPIENTS; FREUND'S ADJUVANT; IN VITRO TECHNIQUES; LIPIDS; MALE; NANOPARTICLES; PARTICLE SIZE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; SURFACE-ACTIVE AGENTS;

EID: 85014443968     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639045.2017.1291666     Document Type: Article

References (23)

1. Sweeny SE, Fierestein GS., Rheumatoid arthritis:regulation of synovial inflammation. IJBCB 2004;36:372–8.
2. Singh P, Robert MS., Skin permeability and local tissue concentration of non-steroidal anti-inflammatory drugs after topical application. J Pharmcol Exp Ther 1994;268:144–51.
3. Kaur A, Nain P, Nain J., Herbal plant used in rheumatoid arthritis:a review. Int J Pharm Pharm Sci 2012;4:4.
4. Vasavirama K, Upender M., Piperine:a valuable alkaloid from piper species. Inter J Pharm Pharm Sci 2014;6:34–8.
5. Bang JS, Oh DH, Choi HM, et al. Anti inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 2009;11:R49.
6. Bhalekar MR, Upadhaya PG, Nalawade SD, et al. Anti-rheumatic activity of chloroquine-SLN gel on Wistar rats using complete Freund’s adjuvant (CFA) model. Indian J Rheumatol 2015;10:58–64.
7. Bhalekar MR, Upadhaya PG, Madgulkar AR., Fabrication and efficacy evaluation of chloroquine nanoparticles in CFA-induced arthritic rats using TNF-α ELISA. EJPS 2016;84:1–8.
8. Sacchetti M, Nejati E. Prediction of drug solubility in lipid mixtures from the individual ingredients. AAPS PharmSciTech 2012;13:1103–9.
9. Li S, Ji Z, Zou M., Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS PharmSciTech 2011;12:1011–8.
10. Gambhire M, Bhalekar M, Shrivastava B., Bioavailability assessment of simvastatin loaded solid lipid nanoparticles after oral administration. As J of Pharm Sci 2011;6:251–8.
11. Padamwar MN, Pokharkar VB., Development of vitamin loaded topical liposomal formulation using factorial design approach:drug deposition and stability. Int J Pharm 2006;320:37–44.
12. Bhalekar MR, Pokharkar V, Madgulkar A., Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009;10:289–96.
13. Vennishetty VK, Komuravekki R, Kuncha M, et al. Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. Nanomedicine 2013;9:111–21.
14. Das MK, Ahmed AB., Formulation and evaluation of rofecoxib gel for topical application. Acta Pol Pharm 2007;63:461–7.
15. Carter SJ., Cooper and Gunn’s dispersion of pharmaceutical students. 12th edn. Delhi:CBS Publishers and Distributors; 2000. 192–9 p.
16. Mandawgade SD, Patravale VB., Development of SLNs from natural lipids:application to topical delivery of tretinoin. Int J Pharm 2008;363:132–8.
17. fda.gov[Internet]. Rockville, MD:Food and Drug Administration. [cited 2017 Feb 19]. Available from:http://www.fda.gov/cder/guidance/index.htm.
18. Todorovic Z, Medic B, Basta-Jovanovic G, et al. Acute pretreatment with chloroquine attenuates renal I/R. PloS One 2014;9:1–10.
19. Singh B, Bani S, Gupta DK, et al. Anti-inflammatory activity of ‘TAF’ an active fraction from the plant Barleria prionitis Linn. J Ethnopharmacol 2003;85:187–93.
20. Barton NJ, Stevens DA, Hughes JP, et al. Demonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee joints. J Inflamm 2007;4:13.
21. Zimmermann E, Souto EB, Müller RH., Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR. Pharmazie 2005;60:508–13.
22. Mäder K, Mehnert W., Solid lipid nanoparticles:production, characterization and applications. Adv Drug Deliv Rev 2012;64:83–101.
23. Diembeck W, Beck H, Benech-kieffer F., Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem Toxicol 1999;37:191–205.